Paper39768176
Cell-Based Glioma Models for Anticancer Drug Screening: From Conventional Adherent Cell Cultures to Tumor-Specific Three-Dimensional Constructs.
Lanskikh D and 7 others. Cells, 2024. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Cell-Based Glioma Models for Anticancer Drug Screening: From Conventional Adherent Cell Cultures to Tumor-Specific Three-Dimensional Constructs. Papers, record 39768176. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39768176
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cell-Based Glioma Models for Anticancer Drug Screening: From Conventional Adherent Cell Cultures to Tumor-Specific Three-Dimensional Constructs.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glioma | Major topic |
| Drug Screening Assays, Antitumor | Major topic |
| Brain Neoplasms | Major topic |
| Antineoplastic Agents | Major topic |
| Humans | |
| Cell Culture Techniques | |
| Models, Biological | |
| Animals | |
| Cell Line, Tumor | |
| Cell Adhesion |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 20-15-00378п | Russian Science Foundation | PubMed |
Source PubMed
References315
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21532838 | MicroRNA: Biogenesis, Function and Role in Cancer. | Curr Genomics | 2010 | https://conductscience.org/library/papers/21532838 | PubMed |
| 2 | 38724526 | Glioma. | Nat Rev Dis Primers | 2024 | https://conductscience.org/library/papers/38724526 | PubMed |
| 3 | 37444568 | Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37444568 | PubMed |
| 4 | 37343520 | Brain tumors on slice: A novel platform for personalized therapeutic screening. | Cell Rep Med | 2023 | https://conductscience.org/library/papers/37343520 | PubMed |
| 5 | 33009951 | Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology. | Acta Neuropathol | 2020 | https://conductscience.org/library/papers/33009951 | PubMed |
| 6 | 33806933 | Contemporary Mouse Models in Glioma Research. | Cells | 2021 | https://conductscience.org/library/papers/33806933 | PubMed |
| 7 | 39123433 | An Injury-like Signature of the Extracellular Glioma Metabolome. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39123433 | PubMed |
| 8 | 38474286 | Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38474286 | PubMed |
| 9 | 36980765 | The Extracellular Matrix in Glioblastomas: A Glance at Its Structural Modifications in Shaping the Tumoral Microenvironment-A Systematic Review. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36980765 | PubMed |
| 10 | 30909628 | Lentiviral Vectors as Tools for the Study and Treatment of Glioblastoma. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/30909628 | PubMed |
| 11 | 38579724 | Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma. | Cancer Cell | 2024 | https://conductscience.org/library/papers/38579724 | PubMed |
| 12 | 29116016 | Management and potentialities of primary cancer cultures in preclinical and translational studies. | J Transl Med | 2017 | https://conductscience.org/library/papers/29116016 | PubMed |
| 13 | 19139068 | Modulation of gene expression in U251 glioblastoma cells by binding of mutant p53 R273H to intronic and intergenic sequences. | Nucleic Acids Res | 2009 | https://conductscience.org/library/papers/19139068 | PubMed |
| 14 | 38258059 | An Improved In Vitro Blood-Brain Barrier Model for the Evaluation of Drug Permeability Using Transwell with Shear Stress. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/38258059 | PubMed |
| 15 | 20388696 | Oligodendroglioma cell lines containing t(1;19)(q10;p10). | Neuro Oncol | 2010 | https://conductscience.org/library/papers/20388696 | PubMed |
| 16 | 38817336 | Role of glioma stem cells in promoting tumor chemo- and radioresistance: A systematic review of potential targeted treatments. | World J Stem Cells | 2024 | https://conductscience.org/library/papers/38817336 | PubMed |
| 17 | 30781398 | Detecting Chromosome Instability in Cancer: Approaches to Resolve Cell-to-Cell Heterogeneity. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/30781398 | PubMed |
| 18 | 29196443 | Modelling glioblastoma tumour-host cell interactions using adult brain organotypic slice co-culture. | Dis Model Mech | 2018 | https://conductscience.org/library/papers/29196443 | PubMed |
| 19 | 22837387 | Transforming fusions of FGFR and TACC genes in human glioblastoma. | Science | 2012 | https://conductscience.org/library/papers/22837387 | PubMed |
| 20 | 20126413 | U87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line. | PLoS Genet | 2010 | https://conductscience.org/library/papers/20126413 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42931829 | Modelling glioblastoma with organoids and assembloids: Opportunities and challenges. | Med Oncol | 2026 | https://conductscience.org/library/papers/42931829 | PubMed |
| 42649915 | Construction Strategies, Microenvironmental Modelling and Precision-Therapy Applications of Glioma Organoid Models. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42649915 | PubMed |
| 42292357 | TRIM47: molecular characteristics, disease-related mechanisms, and clinical translational value. | Front Immunol | 2026 | https://conductscience.org/library/papers/42292357 | PubMed |
| 41874927 | Engineering Mesenchymal Stem Cell Spheroids and Brain Organoids: Advanced 3D Culture Platforms for Neurodegenerative Disease Cell Therapy. | Stem Cell Rev Rep | 2026 | https://conductscience.org/library/papers/41874927 | PubMed |
| 40422249 | All-Trans Retinoic Acid Induces Differentiation and Downregulates Stemness Markers and MGMT Expression in Glioblastoma Stem Cells. | Cells | 2025 | https://conductscience.org/library/papers/40422249 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39768176
GET https://conductscience.org/api/papers/v1/39768176/references?page=2